SCHEMBL20799508

SCHEMBL20799508

COc1ccc2ncc(-c3ccccc3)c(C)c2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
GABRA1 P14867 1/20 0.48
GABRG2 P18507 1/20 0.48
GABRB3 P28472 1/20 0.48
GABRA5 P31644 1/20 0.48
GABRA3 P34903 1/20 0.48
GABRA2 P47869 1/20 0.48
EGFR P00533 3/20 0.47
ACACA Q13085 1/20 0.47
CSF1R P07333 2/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
NCOA1 Q15788 1/20 0.45
NCOA3 Q9Y6Q9 1/20 0.45
AURKA O14965 1/20 0.45
AURKB Q96GD4 1/20 0.45
PIN1 Q13526 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20474256 0.85 KDM4E (0.53) KDM4EMEN1KMT2ASMN1; SMN2GABRA1
SCHEMBL20474189 0.81 ALDH1A1 (0.50) KDM4EMEN1KMT2AALDH1A1CYP3A4
SCHEMBL20474245 0.79 PRNP (0.45) MEN1KMT2ASMN1; SMN2GABRA1GABRG2
SCHEMBL30440258 0.79 PIK3CA (0.57) KDM4EMEN1KMT2ASMN1; SMN2EGFR
SCHEMBL13865282 0.78 POLB (0.47) KDM4EGABRA1GABRG2GABRB3GABRA5
SCHEMBL28176611 0.78 PSMB5 (0.51) KDM4EMEN1KMT2ACSF1RALDH1A1
SCHEMBL11166756 0.77 TLR7 (0.51) KDM4ESMN1; SMN2ALDH1A1MAPTHPGD
SCHEMBL17967312 0.77 ALDH1A1 (0.49) KDM4EKMT2ASMN1; SMN2GABRA1GABRG2
SCHEMBL28494948 0.76 AURKA (0.57) KDM4EMEN1KMT2ASMN1; SMN2ACACA
SCHEMBL28350370 0.74 KDM4E (0.75) KDM4EMEN1KMT2ASMN1; SMN2ACACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10227355-B2 Quinoline derivatives and preparation thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2019-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10227355-B2 Quinoline derivatives and preparation thereof ABL1, FLT3, MAP3K7 KDM4E 939/4885MEN1 1505/4885KMT2A 870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.